Market Indices
Sector Heatmap
HRTX — Heron Therapeutics, Inc.
NasdaqHeron Therapeutics, Inc.
- O
- 0.36
- H
- 0.38
- L
- 0.35
- V
- 2.93M
HRTX — Latest News & Headlines
11 StoriesHeron Therapeutics Stock Price Forecast. Should You Buy HRTX? - StockInvest.us
Heron Therapeutics Stock Price Forecast. Should You Buy HRTX? StockInvest.us
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Has Consensus Target Price of $2.00 - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Has Consensus Target Price of $2.00 MarketBeat
SPXW 261002 7685.00P (SPXW261002P7685000) Stock Options Chain | Quotes & News - Moomoo
SPXW 261002 7685.00P (SPXW261002P7685000) Stock Options Chain | Quotes & News Moomoo
PTC Therapeutics grants stock options and RSUs to 37 new employees as hiring incentives. - pluang.com
PTC Therapeutics grants stock options and RSUs to 37 new employees as hiring incentives. pluang.com
Form 8K Heron Therapeutics Inc For: 29 September By Investing.com - Investing.com Nigeria
Form 8K Heron Therapeutics Inc For: 29 September By Investing.com Investing.com Nigeria
Heron Therapeutics stock fell 2.33 percent on October 2 - AD HOC NEWS
Heron Therapeutics stock fell 2.33 percent on October 2 AD HOC NEWS
Viking Therapeutics prices $275M stock and conv... - pluang.com
Viking Therapeutics prices $275M stock and conv... pluang.com
Heron Therapeutics signs multi-product license agreement with Long Grove By Investing.com - Investing.com Canada
Heron Therapeutics signs multi-product license agreement with Long Grove By Investing.com Investing.com Canada
NEOG stock drops 7.22% after FDA warns of funga... - pluang.com
NEOG stock drops 7.22% after FDA warns of funga... pluang.com
Cryoport shares jump 82% YTD on strong cell and gene therapy pipeline and profitability rebound - pluang.com
Cryoport shares jump 82% YTD on strong cell and gene therapy pipeline and profitability rebound pluang.com
Class action lawsuit targets CooperCompanies ov... - pluang.com
Class action lawsuit targets CooperCompanies ov... pluang.com